Company description

CNTG, or Centogene NV, is a biotechnology company that focuses on providing genetic testing and precision medicine solutions. The company was founded in 2006 and is headquartered in Rostock, Germany. They operate in a wide range of countries including the United States, India, and Japan and have over 740 employees worldwide. Centogene NV offers a variety of services such as diagnosing rare genetic diseases, providing clinical trial support, and developing personalized treatments for individuals with rare genetic disorders. Their state-of-the-art platform combines genetic testing, clinical data, and artificial intelligence to offer comprehensive solutions for patients and their families. The company has partnerships with leading pharmaceutical companies and has a strong global presence in the precision medicine industry. Additionally, Centogene NV is committed to advancing scientific research and has published over 500 scientific articles in respected journals. Their dedication to improving the lives of individuals with rare diseases, coupled with their innovative approach, makes Centogene NV a leader in the field of precision medicine.